Virpax Pharmaceuticals (VRPX) Q3 2024 Earnings

13AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-2.75
-1.83
-0.92
0

Details

Expected EPS
-1.53
Actual EPS
-1.75
Surprise EPS
-0.22
Surprise Percent
+14.38%

Description

Virpax Pharmaceuticals (VRPX) has reported earnings of -1.75 per share for Q3 2024.

0 Comments

Share your thoughts